Nanoviricides Stock Market Value
| NNVC Stock | USD 0.96 0.02 2.13% |
| Symbol | NanoViricides |
Will Biotechnology sector continue expanding? Could NanoViricides diversify its offerings? Factors like these will boost the valuation of NanoViricides. Anticipated expansion of NanoViricides directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every NanoViricides data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding NanoViricides requires distinguishing between market price and book value, where the latter reflects NanoViricides's accounting equity. The concept of intrinsic value - what NanoViricides' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push NanoViricides' price substantially above or below its fundamental value.
It's important to distinguish between NanoViricides' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NanoViricides should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, NanoViricides' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
NanoViricides 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NanoViricides' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NanoViricides.
| 12/04/2025 |
| 03/04/2026 |
If you would invest 0.00 in NanoViricides on December 4, 2025 and sell it all today you would earn a total of 0.00 from holding NanoViricides or generate 0.0% return on investment in NanoViricides over 90 days. NanoViricides is related to or competes with Verrica Pharmaceuticals, Jasper Therapeutics, SAB Biotherapeutics, Evaxion Biotech, India Globalization, Q32 Bio, and MAIA Biotechnology. NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes ... More
NanoViricides Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NanoViricides' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NanoViricides upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 24.18 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 7.44 |
NanoViricides Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NanoViricides' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NanoViricides' standard deviation. In reality, there are many statistical measures that can use NanoViricides historical prices to predict the future NanoViricides' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | (0.33) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NanoViricides' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NanoViricides March 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.32) | |||
| Mean Deviation | 3.49 | |||
| Coefficient Of Variation | (1,377) | |||
| Standard Deviation | 4.52 | |||
| Variance | 20.39 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | (0.33) | |||
| Maximum Drawdown | 24.18 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 7.44 | |||
| Skewness | 1.01 | |||
| Kurtosis | 1.78 |
NanoViricides Backtested Returns
NanoViricides has Sharpe Ratio of -0.0726, which conveys that the firm had a -0.0726 % return per unit of risk over the last 3 months. NanoViricides exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify NanoViricides' Risk Adjusted Performance of (0.05), mean deviation of 3.49, and Standard Deviation of 4.52 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.03, which conveys a somewhat significant risk relative to the market. NanoViricides returns are very sensitive to returns on the market. As the market goes up or down, NanoViricides is expected to follow. At this point, NanoViricides has a negative expected return of -0.33%. Please make sure to verify NanoViricides' potential upside, as well as the relationship between the daily balance of power and price action indicator , to decide if NanoViricides performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.44 |
Average predictability
NanoViricides has average predictability. Overlapping area represents the amount of predictability between NanoViricides time series from 4th of December 2025 to 18th of January 2026 and 18th of January 2026 to 4th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NanoViricides price movement. The serial correlation of 0.44 indicates that just about 44.0% of current NanoViricides price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.44 | |
| Spearman Rank Test | 0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether NanoViricides offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NanoViricides' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nanoviricides Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nanoviricides Stock:Check out NanoViricides Correlation, NanoViricides Volatility and NanoViricides Performance module to complement your research on NanoViricides. For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
NanoViricides technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.